No. |
DrugBank |
Drug (Description in trials) [Number of descriptions] |
KEGG DRUG * | KEGG GENES * [Number of genes] |
KEGG PATHWAY [Number of pathways] |
Disease ID * [Number of diseases] |
1 | Ademetionine | - | D07128 |
- |
- |
[15] 6, 14, 22, 43, 44, 46, 47, 49, 50, 60, 84, 93, 96, 97, 172 |
2 | Basic Fibroblast Growth Factor | [1] Basic fibroblast growth factor; | - |
- |
- |
[1] 47 |
3 | Bosentan | [14] Bosentan; Bosentan (tracleer); Bosentan 125 mg; Bosentan 62.5 mg; Bosentan administration; Bosentan and sildenafil; Bosentan group; Bosentan monohydrat; Bosentan monohydrate; Bosentan mylan; Bosentan, ambrisentan; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Sildenafil 20mg and bosentan 62.5mg; Sildenafil singly or in association with bosentan; | D01227 D07538 |
[2] EDNRA, EDNRB |
[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
4 | Erythropoietin | [4] Erythropoietin; Erythropoietin human recombinant (eporh); Recombinant human erythropoietin; Recombinant human erythropoietin(rhepo); | D03231 |
[1] EPOR |
[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
[9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
5 | Gelatin | [3] Bio-enhanced curcumin soft gelatin capsule; Gelatin; Neoral soft gelatin capsules; | D00115 D06892 |
- |
- |
[4] 47, 78, 97, 269 |
6 | Thrombopoietin | [3] Combination of thrombopoietin mimetic and cyclosporin a; Recombinant human thrombopoietin (rhtpo); Thrombopoietin; | - |
- |
- |
[3] 47, 60, 63 |
7 | Trafermin | [1] Trafermin; | D03362 |
- |
- |
[1] 47 |